Visit adherence
Between baseline and week 24, 202/203 (99.5%) of participants in ANC, 192/197 (97.5%) in OPD and 210/212 (99.1%) in community settings remained eligible for intervention delivery (four withdrew and four seroconverted; zero died). At week 4 following randomization, 84% of ANC, 89% of OPD and 98% of eligible community participants were seen and offered a dynamic choice of product, test modality and location for the next visit. Visit adherence remained high across all trial settings at weeks 12 (95% ANC, 92% OPD and 91% community participants seen) and 24 (92% ANC, 89% OPD and 89% community).